Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TERF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAV1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR76 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCNX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERCC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERBIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DENND4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR636 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RWDD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on